Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
12 03 2021
Historique:
received: 14 12 2020
accepted: 08 02 2021
revised: 08 02 2021
entrez: 13 3 2021
pubmed: 14 3 2021
medline: 23 3 2021
Statut: epublish

Résumé

The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients. SARS-CoV-2 induces rapid death associated with profound ultrastructural changes in Vero cells. Type II pneumocytes in lung tissue showed prominent altered features with numerous vacuoles and swollen mitochondria with presence of abundant lipid droplets. The accumulation of lipids was the most striking finding we observed in SARS-CoV-2 infected cells, both in vitro and in the lungs of patients, suggesting that lipids can be involved in SARS-CoV-2 pathogenesis. Considering that in most cases, COVID-19 patients show alteration of blood cholesterol and lipoprotein homeostasis, our findings highlight a peculiar important topic that can suggest new approaches for pharmacological treatment to contrast the pathogenicity of SARS-CoV-2.

Identifiants

pubmed: 33712574
doi: 10.1038/s41419-021-03527-9
pii: 10.1038/s41419-021-03527-9
pmc: PMC7952828
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

263

Subventions

Organisme : Regione Lazio (Region of Lazio)
ID : E56C18000460002

Références

Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
pubmed: 31978945 pmcid: 7092803 doi: 10.1056/NEJMoa2001017
WHO 2020. Coronavirus disease (COVID-19) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports-update (2020).
Martines, R. B. et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg. Infect. Dis. 26, 2005–2015 (2020).
pubmed: 32437316 pmcid: 7454055 doi: 10.3201/eid2609.202095
Shi, Y. et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 27, 1451–1454 (2020).
pubmed: 32205856 doi: 10.1038/s41418-020-0530-3 pmcid: 7091918
Celardo, I., Pace, L., Cifaldi, L., Gaudio, C. & Barnaba, V. The immune system view of the coronavirus SARS-CoV-2. Biol. Direct 15, 30 (2020).
pubmed: 33371901 pmcid: 7769684 doi: 10.1186/s13062-020-00283-2
Khosroshahi L. M. & Rezaei N. Dysregulation of the immune response in COVID-19. Cell Biol. Int. https://doi.org/10.1002/cbin.11517 (2020).
Taefehshokr, N., Taefehshokr, S. & Heit, B. Mechanisms of dysregulated humoral and cellular immunity by SARS-CoV-2. Pathogens 9, E1027 (2020).
pubmed: 33302366 doi: 10.3390/pathogens9121027
Menter, T. et al. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology 77, 198–209 (2020).
pubmed: 32364264 pmcid: 7496150 doi: 10.1111/his.14134
Falasca, L. et al. Post-mortem findings in Italian patients with COVID-19 - a descriptive full autopsy study of cases with and without co-morbidities. J. Infect. Dis. 222, 1807–1815 (2020).
pubmed: 32914853 doi: 10.1093/infdis/jiaa578
Del Nonno, F., Colombo, D., Nardacci, R. & Falasca, L. Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization. Thromb. J. 19, 1 (2021).
pubmed: 33407578 pmcid: 7785914 doi: 10.1186/s12959-020-00255-6
Tan, Y. K. et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J. Thromb. Thrombolysis 50, 587–595 (2020).
pubmed: 32661757 doi: 10.1007/s11239-020-02228-y
Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220 (2020).
pubmed: 32225176 doi: 10.1038/s41586-020-2180-5
Goldsmith, C. S., Miller, S. E., Martines, R. B., Bullock, H. A. & Zaki, S. R. Electron microscopy of SARS-CoV-2: a challenging task. Lancet 395, e99 (2020).
pubmed: 32442529 pmcid: 7237172 doi: 10.1016/S0140-6736(20)31188-0
Philips, C. A., Ahamed, R. & Augustine, P. SARS-CoV-2 related liver impairment - perception may not be the reality. J. Hepatol. 73, 991–992 (2020).
pubmed: 32454042 pmcid: 7255210 doi: 10.1016/j.jhep.2020.05.025
Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020).
pubmed: 32075877 pmcid: 7164637 doi: 10.1126/science.abb2507
Wei, C., et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. https://doi.org/10.1038/s42255-020-00324-0 (2020).
Gillespie, L. K., Hoenen, A., Morgan, G. & Mackenzie, J. M. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J. Virol. 84, 10438–10447 (2010).
pubmed: 20686019 pmcid: 2950591 doi: 10.1128/JVI.00986-10
Maier, H. J. et al. Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes. mBio 4, e00801–e00813 (2013).
pubmed: 24149513 pmcid: 3812713 doi: 10.1128/mBio.00801-13
Hayashi, H., Winship, D. H. & Sternlieb, I. Lipolysosomes in human liver: distribution in livers with fatty infiltration. Gastroenterology 73, 651–654 (1977).
pubmed: 892368 doi: 10.1016/S0016-5085(19)31759-7
Memish, Z. A., Perlman, S., Van Kerkhove, M. D. & Zumla, A. Middle East respiratory syndrome. Lancet 395, 1063–1077 (2020).
pubmed: 32145185 pmcid: 7155742 doi: 10.1016/S0140-6736(19)33221-0
Shereen, M. A., Khan, S., Kazmi, A., Bashir, N. & Siddique, R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 24, 91–98 (2020).
pubmed: 32257431 pmcid: 7113610 doi: 10.1016/j.jare.2020.03.005
Lai M. M. C. & Holmes K. V. Coronaviridae. in Fields virology 4th edn (eds. Knipe D. M., Howley P. M., Griffin D. E., Lamb R. A., Martin M. A., Roizman B. & Straus S. E.) p. 1163–1185 (Lippincott Williams & Wilkins, Philadelphia (PA), 2001).
Buonvino, S. & Melino, S. New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell-cell fusion. Cell Death Discov. 6, 134 (2020).
pubmed: 33262894 pmcid: 7691694 doi: 10.1038/s41420-020-00372-1
Su, S. et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24, 490–502 (2016).
pubmed: 27012512 pmcid: 7125511 doi: 10.1016/j.tim.2016.03.003
Ulasli, M., Verheije, M. H., de Haan, C. A. M. & Reggiori, F. Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell Microbiol. 12, 844–861 (2010).
pubmed: 20088951 pmcid: 7159092 doi: 10.1111/j.1462-5822.2010.01437.x
V’Kovski, P., Al-Mulla, H., Thiel, V. & Neuman, B. W. New insights on the role of paired membrane structures in coronavirus replication. Virus Res. 202, 33–40 (2015).
pubmed: 25550072 doi: 10.1016/j.virusres.2014.12.021
Müller, C. et al. Inhibition of cytosolic phospholipase A2α impairs an early step of coronavirus replication in cell culture. J. Virol. 92, e01463–17 (2018).
pubmed: 29167338 pmcid: 5790932 doi: 10.1128/JVI.01463-17
Knoops, K. et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 6, e226 (2008).
pubmed: 18798692 pmcid: 2535663 doi: 10.1371/journal.pbio.0060226
Orenstein, J. M., Banach, B. & Baker, S. C. Morphogenesis of coronavirus HCoV-NL63 in cell culture: a transmission electron microscopic study. Open Infect. Dis. J. 2, 52–58 (2008).
pubmed: 19844604 pmcid: 2763395 doi: 10.2174/1874279300802010052
Maier, H. J. et al. Extensive coronavirus-induced membrane rearrangements are not a determinant of pathogenicity. Sci. Rep. 6, 27126 (2016).
pubmed: 27255716 pmcid: 4891661 doi: 10.1038/srep27126
Qin, P. et al. Characteristics of the life cycle of porcine deltacoronavirus (PDCoV) in vitro: replication kinetics, cellular ultrastructure and virion morphology, and evidence of inducing autophagy. Viruses 11, 455 (2019).
pmcid: 6563515 doi: 10.3390/v11050455
Yan, B. et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses 11, 73 (2019).
pmcid: 6357182 doi: 10.3390/v11010073
Glende, J. et al. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology 381, 215–221 (2008).
pubmed: 18814896 doi: 10.1016/j.virol.2008.08.026
Zhang, Z. et al. Host lipids in positive-strand RNA virus genome replication. Front. Microbiol. 10, 286 (2019).
pubmed: 30863375 pmcid: 6399474 doi: 10.3389/fmicb.2019.00286
Sagan, S. M. et al. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication. Biochem. Cell Biol. 84, 67–79 (2006).
pubmed: 16462891 doi: 10.1139/o05-149
Thiam, A. R. & Dugail, I. Lipid droplet-membrane contact sites - from protein binding to function. J. Cell Sci. 132, jcs230169 (2019).
pubmed: 31209063 doi: 10.1242/jcs.230169
Benador, I. Y., Veliova, M., Liesa, M. & Shirihai, O. S. Mitochondria bound to lipid droplets: where mitochondrial dynamics regulate lipid storage and utilization. Cell Metab. 29, 827–835 (2019).
pubmed: 30905670 pmcid: 6476311 doi: 10.1016/j.cmet.2019.02.011
Dorobantu, C. M. et al. Modulation of the host lipid landscape to promote RNA virus replication: the picornavirus encephalomyocarditis virus converges on the pathway used by Hepatitis C virus. PLoS Pathog. 11, e1005185 (2015).
pubmed: 26406250 pmcid: 4583462 doi: 10.1371/journal.ppat.1005185
Villareal, V. A., Rodgers, M. A., Costello, D. A. & Yang, P. L. Targeting host lipid synthesis and metabolism to inhibit dengue andhepatitis C viruses. Antivir. Res. 124, 110–121 (2015).
pubmed: 26526588 doi: 10.1016/j.antiviral.2015.10.013
Episcopio, D. et al. Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus. FASEB J. 33, 9516–9525 (2019).
pubmed: 31125254 pmcid: 6662987 doi: 10.1096/fj.201900428RR
Yan, H. et al. SARS coronavirus induces apoptosis in Vero E6 cells. J. Med. Virol. 73, 323–331 (2004).
pubmed: 15170624 pmcid: 7166321 doi: 10.1002/jmv.20094
Bordi, L. et al. Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics. Arch. Virol. 151, 369–377 (2006).
pubmed: 16155806 doi: 10.1007/s00705-005-0632-8
Man, S. M., Karki, R. & Kanneganti, T. D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol. Rev. 277, 61–75 (2017).
pubmed: 28462526 pmcid: 5416822 doi: 10.1111/imr.12534
Sauler, M., Bazan, I. S. & Lee, P. J. Cell death in the lung: the apoptosis-necroptosis axis. Annu. Rev. Physiol. 81, 375–402 (2019).
pubmed: 30485762 doi: 10.1146/annurev-physiol-020518-114320
Albarello, F. et al. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation.; COVID 19 INMI Study Group. Int. J. Infect. Dis. 93, 192–197 (2020).
pubmed: 32112966 pmcid: 7110436 doi: 10.1016/j.ijid.2020.02.043
Hanley, B., Lucas, S. B., Youd, E., Swift, B. & Osborn, M. Autopsy in suspected COVID-19 cases. J. Clin. Pathol. 73, 239–242 (2020).
pubmed: 32198191 doi: 10.1136/jclinpath-2020-206522
Baiocchini, A. et al. Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. Sci. Rep. 9, 8760 (2019).
pubmed: 31217430 pmcid: 6584733 doi: 10.1038/s41598-019-45114-1
Nardacci, R. et al. Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients. Autophagy 10, 1167–1178 (2014).
pubmed: 24813622 pmcid: 4203545 doi: 10.4161/auto.28678

Auteurs

Roberta Nardacci (R)

Laboratory of Electron Microscopy, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Francesca Colavita (F)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Concetta Castilletti (C)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Daniele Lapa (D)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Giulia Matusali (G)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Silvia Meschi (S)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Franca Del Nonno (F)

Pathology Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Daniele Colombo (D)

Pathology Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Maria Rosaria Capobianchi (MR)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Alimuddin Zumla (A)

Department of Infection, Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.

Giuseppe Ippolito (G)

Scientific Direction; National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Mauro Piacentini (M)

Laboratory of Electron Microscopy, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.
Department of Biology, University of Rome "Tor Vergata", Rome, Italy.

Laura Falasca (L)

Laboratory of Electron Microscopy, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy. laura.falasca@inmi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH